Document is current

Any future updates will be listed below

Correction to: Vitiligo and tumor response in a patient with amelanotic melanoma undergoing nivolumab treatment

Crossref DOI link: https://doi.org/10.1007/s13691-021-00517-8

Published Online: 2021-10-26

Published Print: 2022-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark